3D bioprinting in a 2D regulatory landscape: gaps, uncertainties, and problems (2020)

First Author: Li P

Attributed to: Biomodifying technologies and experimental space: organisational and regulatory implications for the translation and valuation of health research. funded by ESRC

No abstract provided

Type: Journal Article/Review

Parent Publication: Law, Innovation and Technology

Issue: 1